-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tango Therapeutics, Raises Price Target to $35

Benzinga·08/12/2026 12:24:46
Listen to the news
Guggenheim analyst Michael Schmidt maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $32 to $35.